Ocugen’s Financial Crossroads: Clinical Milestones Amid Mounting Losses
Biopharmaceutical firm Ocugen finds itself navigating a complex landscape of promising clinical developments and challenging financial realities. The company’s latest quarterly report reveals a troubling…


